{
    "2021-10-25": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Buy This Great High-Yield Dividend Stock?",
                "features": {
                    "keywords": [
                        "High-Yield",
                        "Dividend",
                        "Stock"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Stock Sinks",
                        "Market Gains"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-05-20",
                "original_text": "Investors in AbbVie (NYSE:ABBV) have made a strong return of 138% over the past five years",
                "features": {
                    "keywords": [
                        "Investors",
                        "AbbVie",
                        "strong return",
                        "138%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-12",
                "original_text": "What Could These Clinical Results Mean for AbbVie's Shareholders?",
                "features": {
                    "keywords": [
                        "Clinical Results",
                        "AbbVie",
                        "Shareholders"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}